2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer (Q34114674)

31 July 2017

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer (English)

1 reference

31 July 2017

0 references

Thierry Calandra

6

0 references

author name string

Walter T Hughes

1

1 reference

31 July 2017

Donald Armstrong

2

1 reference

31 July 2017

Gerald P Bodey

3

1 reference

31 July 2017

Eric J Bow

4

1 reference

31 July 2017

Arthur E Brown

5

1 reference

31 July 2017

Ronald Feld

7

1 reference

31 July 2017

Philip A Pizzo

8

1 reference

31 July 2017

Kenneth V I Rolston

9

1 reference

31 July 2017

Jerry L Shenep

10

1 reference

31 July 2017

Lowell S Young

11

1 reference

31 July 2017

language of work or name

English

0 references

publication date

13 February 2002

1 reference

Clinical Infectious Diseases

31 July 2017

1 reference

31 July 2017

34

1 reference

31 July 2017

730-751

1 reference

31 July 2017

6

1 reference

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

31 July 2017

1 reference

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

21 January 2018

1 reference

Guidelines for the management of intravascular catheter-related infections

21 January 2018

1 reference

Current blood culture methods and systems: clinical concepts, technology, and interpretation of results

21 January 2018

1 reference

Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward

21 January 2018

1 reference

Controlled comparison of BacT/ALERT FAN aerobic medium and BATEC fungal blood culture medium for detection of fungemia

21 January 2018

1 reference

Practice guidelines for the management of infectious diarrhea

21 January 2018

1 reference

Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography.

21 January 2018

1 reference

Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia

21 January 2018

1 reference

Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.

21 January 2018

1 reference

Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy

21 January 2018

1 reference

Bacteremia due to viridans streptococci in neutropenic patients: a review

21 January 2018

1 reference

Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients. CEMIC (French-Belgian Study Club of Infectious Diseases in Cancer).

21 January 2018

1 reference

Febrile neutropenia in cancer patients in Kuwait: microbial spectrum and outcome

21 January 2018

1 reference

Prospective study of infections in indwelling central venous catheters using quantitative blood cultures.

21 January 2018

1 reference

An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.

21 January 2018

1 reference

Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration

21 January 2018

1 reference

Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy

21 January 2018

1 reference

Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients

21 January 2018

1 reference

Beta-lactam regimens for the febrile neutropenic patient

21 January 2018

1 reference

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

21 January 2018

1 reference

New trends in patient management: risk-based therapy for febrile patients with neutropenia

21 January 2018

1 reference

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

21 January 2018

1 reference

Early discharge of low-risk febrile neutropenic children and adolescents with cancer

21 January 2018

1 reference

"Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia

21 January 2018

1 reference

Predicting the risk of bacteremia in childen with fever and neutropenia

21 January 2018

1 reference

Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition

21 January 2018

1 reference

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

21 January 2018

1 reference

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

21 January 2018

1 reference

Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer

21 January 2018

1 reference

Oral administration of cefixime to lower risk febrile neutropenic children with cancer

21 January 2018

1 reference

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

21 January 2018

1 reference

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

21 January 2018

1 reference

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

21 January 2018

1 reference

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

21 January 2018

1 reference

Home treatment of febrile neutropenia: an empirical oral antibiotic regimen

21 January 2018

1 reference

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

21 January 2018

1 reference

A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients

21 January 2018

1 reference

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).

21 January 2018

1 reference

A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

21 January 2018

1 reference

Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial

21 January 2018

1 reference

Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients

21 January 2018

1 reference

Is monotherapy for febrile neutropenia still a viable alternative?

21 January 2018

1 reference

Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey

21 January 2018

1 reference

Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial

21 January 2018

1 reference

Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients

21 January 2018

1 reference

High dose intravenous ciprofloxacin in febrile neutropenic patients

21 January 2018

1 reference

A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients

21 January 2018

1 reference

Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients

21 January 2018

1 reference

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of C

21 January 2018

1 reference

Effects of the combination of gentamicin and carbenicillin on the bactericidal activity of serum

21 January 2018

1 reference

Empirical therapy for febrile, neutropenic patients: persistence of susceptibility of gram-negative bacilli to aminoglycoside antibiotics.

21 January 2018

1 reference

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers

21 January 2018

1 reference

Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor

21 January 2018

1 reference

Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes

21 January 2018

1 reference

Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons

21 January 2018

1 reference

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

21 January 2018

1 reference

Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors

21 January 2018

1 reference

Aztreonam plus Vancomycin versus Gentamicin plus Piperacillin as Empirical Therapy for the Treatment of Fever in Neutropenic Patients: a Randomised Controlled Study

21 January 2018

1 reference

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

21 January 2018

1 reference

A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients

21 January 2018

1 reference

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity

21 January 2018

1 reference

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients

21 January 2018

1 reference

Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia i

21 January 2018

1 reference

Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients

21 January 2018

1 reference

Reduced requirement for antibiotic therapy targeting gram-negative organisms in febrile, neutropenic patients with cancer who are receiving antibacterial chemoprophylaxis with oral quinolones

21 January 2018

1 reference

Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care

21 January 2018

1 reference

Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient

21 January 2018

1 reference

Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: Implications for discontinuation of antibiotics and early discharge from the hospital

21 January 2018

1 reference

Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study

21 January 2018

1 reference

Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients

21 January 2018

1 reference

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia

21 January 2018

1 reference

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

21 January 2018

1 reference

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

21 January 2018

1 reference

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

21 January 2018

1 reference

Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination

21 January 2018

1 reference

Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia

21 January 2018

1 reference

Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?

21 January 2018

1 reference

Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin

21 January 2018

1 reference

Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia

21 January 2018

1 reference

Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT.

21 January 2018

1 reference

Use of abdominal computed tomography for identifying disseminated fungal infection in pediatric cancer patients

21 January 2018

1 reference

Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy

21 January 2018

1 reference

Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation.

21 January 2018

1 reference

Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases

21 January 2018

1 reference

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia

21 January 2018

1 reference

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever

21 January 2018

1 reference

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

21 January 2018

1 reference

Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.

21 January 2018

1 reference

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors

21 January 2018

1 reference

Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients

21 January 2018

1 reference

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

21 January 2018

1 reference

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

21 January 2018

1 reference

Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma

21 January 2018

1 reference

Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?

21 January 2018

1 reference

Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia

21 January 2018

1 reference

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

21 January 2018

1 reference

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

21 January 2018

1 reference

Superinfections by Escherichia coli resistant to fluoroquinolones in immunocompromised patients

21 January 2018

1 reference

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

21 January 2018

1 reference

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

21 January 2018

1 reference

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

21 January 2018

1 reference

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

21 January 2018

1 reference

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

21 January 2018

1 reference

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

21 January 2018

1 reference

Stopping antibiotic therapy in neutropenic patients

21 January 2018

1 reference

Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics

21 January 2018

1 reference

Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer

21 January 2018

1 reference

Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/339215

1 reference

31 July 2017

1 reference